Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Vascular risk factors for COVID-19 ARDS: endothelium, contact-kinin system. | Front Med (Lausanne) | 2023 | 37448794 | PubTator, text mining | PubMed |
| Genetic insight into the putative causal proteins and druggable targets of osteoporosis: a large-scale proteome-wide mendelian randomization study. | Front Genet | 2023 | 37448626 | PubTator, text mining | PubMed |
| The host transcriptome change involved in the inhibitory effect of exogenous interferon-γ on Getah virus replication. | Front Microbiol | 2023 | 37448574 | PubTator, text mining | PubMed |
| Patient-rated angioedema severity using a novel photo-aid for predicting non-mast cell mediator-induced angioedema diagnosis. | World Allergy Organ J | 2023 | 37435178 | PubTator, text mining | PubMed |
| Citrullination of C1-inhibitor as a mechanism of impaired complement regulation in rheumatoid arthritis. | Front Immunol | 2023 | 37426666 | PubTator, text mining | PubMed |
| Dupilumab-Associated Angioedema in an Adult: A Case Report of an Adverse Event and Literature Review. | Cureus | 2023 | 37426396 | PubTator, text mining | PubMed |
| Transcriptome analysis of human macrophages upon chikungunya virus (CHIKV) infection reveals regulation of distinct signaling and metabolic pathways during the early and late stages of infection. | Heliyon | 2023 | 37408916 | PubTator, text mining | PubMed |
| Differentiating between activation via the lectin or the classical complement pathway in patients with systemic lupus erythematosus. | Clin Exp Immunol | 2023 | 37407023 | PubTator, text mining | PubMed |
| Major depressive disorder plays a vital role in the pathway from gastroesophageal reflux disease to chronic obstructive pulmonary disease: a Mendelian randomization study. | Front Genet | 2023 | 37404328 | PubTator, text mining | PubMed |
| C1 inhibitor and prolylcarboxypeptidase modulate prekallikrein activation on endothelial cells. | J Allergy Clin Immunol | 2023 | 37399947 | PubTator, text mining | PubMed |
| Hereditary Angioedema. | Immunol Allergy Clin North Am | 2023 | 37394258 | PubTator, text mining | PubMed |
| Experience of lanadelumab administration in hereditary angioedema: A case series of 4 patients in Portugal. | Asia Pac Allergy | 2023 | 37388816 | PubTator, text mining | PubMed |
| Management of hereditary angioedema in resource-constrained settings: A consensus statement from Indian subcontinent. | Asia Pac Allergy | 2023 | 37388810 | PubTator, text mining | PubMed |
| Conformational dynamics of complement protease C1r inhibitor proteins from Lyme disease- and relapsing fever-causing spirochetes. | J Biol Chem | 2023 | 37380082 | PubTator, text mining | PubMed |
| Rewiring Drug Research and Development through Human Data-Driven Discovery (HD3). | Pharmaceutics | 2023 | 37376121 | PubTator, text mining | PubMed |
| Exploring the Potential of Nanotechnology in Pediatric Healthcare: Advances, Challenges, and Future Directions. | Pharmaceutics | 2023 | 37376032 | PubTator, text mining | PubMed |
| A Pilot Cross-Sectional Study of Immunological and Microbiome Profiling Reveals Distinct Inflammatory Profiles for Smokers, Electronic Cigarette Users, and Never-Smokers. | Microorganisms | 2023 | 37374908 | PubTator, text mining | PubMed |
| New Insights into Immunopathology Associated to Bothrops lanceolatus Snake Envenomation: Focus on PLA2 Toxin. | Int J Mol Sci | 2023 | 37373079 | PubTator, text mining | PubMed |
| Longitudinal whole blood transcriptomic analysis characterizes neutrophil activation and interferon signaling in moderate and severe COVID-19. | Sci Rep | 2023 | 37365222 | PubTator, text mining | PubMed |
| Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment. | Clin Cancer Res | 2023 | 37364001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=26